
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Neurol.
Sec. Applied Neuroimaging
Volume 16 - 2025 | doi: 10.3389/fneur.2025.1488420
This article is part of the Research Topic Advanced fNIRS Applications in Neuroscience and Neurological Disorders View all 16 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objective: The most prevalent types of dementia in older adults are Alzheimer disease (AD) and Lewy body dementia (LBD), and they have overlapping clinical symptoms. We aimed to define amounts of cortical activation and to identify indicators of brain function to better distinguish between these types of dementia and aid diagnosis using functional near-infrared spectroscopy (fNIRS). Methods: Oxygenated hemoglobin (HbO) concentrations in the brains of patients with AD and LBD were detected using fNIRS. Brain function was assessed using a verbal fluency task (VFT). Resting-state and task-state cortical activations were investigated to determine differences between AD and LBD. Blood samples were analyzed to identify relevant biomarkers. The clinical and HbO variables were compared between AD and LBD. Functional connectivity at rest and correlations between HbO variables and blood biomarkers were analyzed. The sensitivity and specificity of the parameters for differentiating the dementias were evaluated using areas under the receiver operating characteristic (ROC) curves (AUCs). Results: This study recruited 28 inpatients with AD and 25 with LBD. Mean HbO concentrations did not significantly differ in the resting state (p > 0.05), whereas functional connectivity significantly differed between the groups. Mean HbO concentrations during the VFT, were significantly lower in the left temporal, right dorsolateral prefrontal, and right temporal (p = 0.011) cortices of the AD, than the LBD group. Blood amyloid-β (Aβ) 42 levels were significantly higher in the AD group (p = 0.023), whereas significantly more α-synuclein was expressed in the LBD group (p = 0.012). Correlation analysis of cognition-related blood biomarkers with HbO concentrations associated higher plasma Aβ 42 level with lower HbO concentrations in the right pre-motor and supplementary motor cortex and higher glial fibrillary acidic protein (GFAP) levels in the lower right pars triangularis at rest. Levels of the blood biomarker Aβ significantly and negatively correlated with HbO concentrations in the right temporal cortex during the VFT. The AUC was significantly higher for the combination of multiple fNIRS indicators compared with individual cognitive or blood indicators (AUC = 0.9314). Conclusion: The characteristics of HbO measured using fNIRS can help distinguish AD from LBD in older adults.
Keywords: cortical activation, Alzheimer Disease, Lewy body dementia, functional near-infrared, biomarker
Received: 30 Aug 2024; Accepted: 17 Mar 2025.
Copyright: © 2025 Ruan, Liang, Liu, Mei and Zheng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Xi Mei, Ningbo Kangning Hospital, Ningbo, China
Chengying Zheng, Affiliated Kangning Hospital of Ningbo University, Ningbo, Zhejiang Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.